Patents by Inventor Michael James Labarre

Michael James Labarre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMEN
    Publication number: 20230405095
    Abstract: Provided are combination dosing regimens comprising administering cabotegravir and hyaluronidase. Combinations and compositions containing the cabotegravir and hyaluronidase are provided. The dosing regimens and combinations are for treating or preventing Human Immunodeficiency Virus (HIV) infection.
    Type: Application
    Filed: June 12, 2023
    Publication date: December 21, 2023
    Inventors: Kelong HAN, Andrew Weber, Michael James Labarre, Jessica Brehm, Nima Akhavein, Emile Velthuisen
  • Stable formulations of a hyaluronan-degrading enzyme
    Patent number: 9993529
    Abstract: Provided are compositions that are stable formulations of a hyaluronan-degrading enzyme or are stable co-formulations of a fast-acting insulin and a hyaluronan degrading enzyme, including a recombinant human PH20 (rHuPH20).
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: June 12, 2018
    Assignee: Halozyme, Inc.
    Inventors: Tzung-Horng Yang, Daniel Edward Vaughn, Michael James Labarre, Christopher L. Caster, Francois Nicol, Donghyun Kim
  • Stable formulations of a hyaluronan-degrading enzyme related applications
    Publication number: 20130022588
    Abstract: Provided are compositions that are stable formulations of a hyaluronan-degrading enzyme or are stable co-formulations of a fast-acting insulin and a hyaluronan degrading enzyme, including a recombinant human PH20 (rHuPH20).
    Type: Application
    Filed: June 15, 2012
    Publication date: January 24, 2013
    Inventors: Tzung-Horng Yang, Daniel Edward Vaughn, Michael James Labarre, Christopher L. Caster, Francois Nicol, Donghyun Kim
  • Stable formulations of a hyaluronan-degrading enzyme
    Publication number: 20130011378
    Abstract: Provided are compositions that are stable formulations of a hyaluronan-degrading enzyme or are stable co-formulations of a fast-acting insulin and a hyaluronan degrading enzyme, including a recombinant human PH20 (rHuPH20).
    Type: Application
    Filed: June 15, 2012
    Publication date: January 10, 2013
    Inventors: Tzung-Horng Yang, Daniel Edward Vaughn, Michael James Labarre, Christopher L. Caster, Francois Nicol, Donghyun Kim